Comparing the current results to its competitors, Organigram Global Inc reported Revenue increase in the 4 quarter 2025 by 62.15 % year on year. The sales growth was above Organigram Global Inc 's competitors' average revenue growth of 19.93 %, achieved in the same quarter.
September 3, 2024
Organigram Secures Second Tranche in Strategic Equity Investment from British American Tobacco Organigram Holdings Inc. (NASDAQ: OGI, TSX: OGI) has demonstrated its ongoing commitment to becoming a leader in the cannabis industry by closing the second tranche of a substantial equity investment from BT DE Investments Inc. a wholly owned subsidiary of British American Tobacco plc (BAT). This pivotal financial step sees Organigram bolstering its position through an aggressive strategic partnership, promising significant growth and development potential. The Second Tranche: A Milestone in Strategic PartnershipOn August 30, 2024, Organigram successfully closed the second of three tranches of the previously announ...
August 7, 2024
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, is thrilled to announce the preliminary results of its pioneering clinical pharmacokinetic (PK) study, marking a significant milestone in cannabis delivery innovation. The study was conducted through Organigram’s Product Development Collaboration (PDC) and focused on its cutting-edge, patent-pending nanoemulsion technology, trademarked as FAST (Fast Acting Soluble Technology). The Innovation of FAST Technology:FAST nanoemulsion technology represents a paradigm shift in how cannabis products are formulated and consumed. Unlike conventional cannabis products that can take up to two hours to exhibit effects, FAST aims ...
June 25, 2024
Organigram Expands Presence in European Cannabis Market with Strategic Investment in Sanity GroupOrganigram Holdings Inc., a leading licensed producer of cannabis, has made its first strategic investment in the European cannabis market by investing 14 million (~C$21 million) in Sanity Group, a prominent German cannabis company. The investment is part of Organigram s to broaden its presence in Europe and capitalize on the growing demand for cannabis products in the region.Using funds from its Jupiter strategic investment pool, Organigram has agreed to provide an initial investment of 11.5 million through an unsecured convertible note and an additional 2.5 million for the acquisition of Sanity Group. This mov...
March 26, 2024
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading Canadian licensed cannabis producer, has recently made a significant move to expand its presence in the United States. The company has announced a minority investment of US $2 million in Steady State LLC, operating as Open Book Extracts (OBX), as part of its first Jupiter Investment. This strategic investment showcases Organigram s commitment to the burgeoning US cannabis market.Based in Roxboro, within North Carolina s Research Triangle, OBX is a renowned legal cannabinoid ingredient producer, focusing on simplifying its clients supply chains by offering a range of one-stop formulation and finished goods manufacturing services. With this new coll...
January 31, 2024
Organigram Holdings Inc., a prominent licensed cannabis producer, has successfully completed its inaugural shipment of bulk dried flower to the medical division of Sanity Group, a leading German cannabis company dedicated to the medical applications of cannabinoids. This exciting step marks Organigram s entry into Germany, which is considered one of the world s largest and fastest-growing medical cannabis markets.Organigram s foray into the German market is a significant milestone for the company. Germany s robust medical cannabis industry presents a vast opportunity for growth and expansion. With a population of over 83 million people, Germany is expected to experience a surge in demand for cannabis-based m...
Fsd Pharma Inc's business model is centered around the development and production of pharmaceutical-grade cannabis products. The company aims to leverage its in-house cultivation facility, research and development capabilities, and strategic partnerships to create innovative cannabis-based therapies for various medical conditions. Fsd Pharma focuses on pursuing licensing and acquisition opportunities to expand its presence in the global cannabis market.
Growgeneration Corp is a retail supplier of hydroponic and organic gardening products. The company operates a chain of stores across the United States, offering a wide range of equipment, nutrients, and other materials needed for cultivating plants indoors. By serving both professional and hobbyist growers, Growgeneration aims to capitalize on the growing demand for sustainable and high-yield agriculture solutions.
The Greater Cannabis Company Inc Share Performance
+58.62%
This Quarter
The Greater Cannabis Company Inc
Profile
The Greater Cannabis Company Inc's business model involves the cultivation, processing, and distribution of cannabis products. They aim to offer a wide range of cannabis-related goods to cater to the demands of both medical and recreational users.
Earth Science Tech Inc is a biotechnology company focused on developing and marketing innovative hemp cannabinoid-based products. Their business model revolves around research, development, manufacturing, and distribution of high-quality CBD and nutraceuticals for various industries, including the pharmaceutical and nutrition sectors.
Sources:
Organigram Global Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Organigram Global Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
